Trump Cuts Insulin Costs for Medicare Enrollees to $35 per Month

2C2K Photography/Flickr

President Donald Trump announced Tuesday a plan that would drastically lower the cost of insulin for Medicare enrollees to $35 a month.

White House counselor Kellyanne Conway said the deal was made with American insulin manufacturers and health care providers to limit a copay for a month’s supply of the drug to $35, or 66 percent of the current price, the New York Post reported.

The initiative would help the one-in-three Medicare enrollees who have diabetes, or approximately three million people.

The announcement comes as the cost of insulin is rising in the U.S. In one case, a diabetic groom-to-be died after taking a cheaper version of the drug to save money for his wedding.

“Having more predictable out of pocket costs will help seniors adhere to their doctor’s orders,” Conway told reporters on a briefing call.

The plan, which will go into effect January 2021, will save seniors 56 percent or $446 on average each year in insulin copays, according to Seema Verma, administrator of the Centers for Medicare and Medicaid Services.


Please let us know if you're having issues with commenting.